##  [EU Rejects Proposed Health Claim Linking Creatine to Cognitive Function Improvement](/index%2ephp/consumer-industry-news/eu-rejects-proposed-health-claim-linking-creatine-to-cognitive-function-improvement) 

May 26, 2026

The European Commission has adopted Implementing Regulation (EU) 2026/1118, refusing the authorization of a health claim that creatine contributes to the improvement of cognitive function. The decision follows an application submitted by Alzchem Trostberg GmbH under Regulation (EC) No 1924/2006 and is based on the scientific assessment conducted by the European Food Safety Authority (EFSA).  
After reviewing the available evidence, EFSA concluded that a cause-and-effect relationship had not been established between creatine consumption and improvements in cognitive performance parameters such as memory, attention, alertness, processing speed, executive function, verbal fluency, and fluid intelligence. As a result, the health claim cannot be used in the marketing, labelling, or advertising of foods within the European Union.



Source

<https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L_202601118>

 

Consumer News Region

- [European Union](/index%2ephp/consumer-news-region/european-union)





 

 

Consumer News Tags

EU-27, Regulation (EU) 2026/1118,creatine,health claim, cognitive function, Food supplements.